SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Guilford (GLFD) - Steadily Rising
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
496 22 0 GLFD
Emcee:  Jim Ball Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
346 I will thank him Steve! He's a Money Manager, as well as my cousin, and I&#Howard Feinstein-3/4/2000
345 Howard, I like your source. Be sure to thank him. take care, steveSteve Smith-3/4/2000
344 Funny you should give that target Steve, because when I got in GLFD in January Howard Feinstein-3/4/2000
343 GLFD has a beautiful chart. GLFD appears to be on the way to a short term targSteve Smith-3/3/2000
342 Guilford Acquires Exclusive Worldwide Rights to Novel Pro-Drug of Propofol, Onesim1-3/2/2000
341 Wednesday February 16, 10:27 am Eastern Time Company Press Release SOURCE: GuJack Hartmann-2/16/2000
340 Quarterly data. GUILFORD PHARMACEUTICALS INC. Jack Hartmann-2/16/2000
339 Guilford Pharmaceuticals Reports 1999 Year-End Results Wednesday, FebrJack Hartmann-2/16/2000
338 I am hoping that we will get a look at how the NIL-A trials are progressing. ISteve-2/6/2000
337 Chart looks bullish, revenue increasing, EPS improving, lead product in phase IJack Hartmann-2/5/2000
336 Hey Steve! I guess Piper Jaffrey was not full of it, as GLFD hit 28 at the closHoward Feinstein-1/19/2000
335 Question about Anti-Kinnen drug Trying to find out if Guilford was given the dBoomba007-12/27/1999
334 News: Guilford Announces Receipt of Amgen Milestone Payment For IND Filing forsim1-12/9/1999
333 Steve, The market is in the mood to punish any stock that runs up prior to eartuck-8/5/1999
332 Maybe whatever Guilford and Amgen do should be kept to themselves. Boy, did thSteve-8/4/1999
331 Guilford and Amgen Announce Start of Neuroimmunophilin Clinical Trials sim1-8/4/1999
330 steve & Thread, NI wrote a while back: "but there are a number of inatuck-7/28/1999
329 Steve, I would guess that they're getting their clients in. Then they'tuck-7/16/1999
328 Guilford is now at $13. Piper Jaffrey target was $13. Is this as high as we gSteve-7/2/1999
327 GLIADEL(R) Wafer Receives Favorable Opinion for Marketing Authorization In Ten sim1-6/28/1999
326 NI, As promised "the" big pharma. Well, actually two or more: Ely tuck-6/24/1999
325 NI, Here's the Austrian company. ebewe.co.at Not the best web page. Clituck-6/24/1999
324 NI, Hey, that's what these forums are for. I never said my list of competuck-6/24/1999
323 Your complaint about the pace of the neuroimmunophilin program is well taken--NeuroInvestment-6/24/1999
322 Steve, As I've said before, GLFD has an interesting neuroscience program, tuck-6/24/1999
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News